T2PD Trademark

Trademark Overview


On Saturday, November 27, 2021, a trademark application was filed for T2PD with the United States Patent and Trademark Office. The USPTO has given the T2PD trademark a serial number of 97144804. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by Orum Therapeutics, Inc.. The T2PD trademark is filed in the Pharmaceutical Products category with the following description:

biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; anti-cancer preparations; pharmaceutical compounds for treating cancer; drugs for medical purposes, namely, pharmaceutical drugs for the prevention and treatment of cancer; medicines for human purposes, namely, for the prevention and treatment of cancer; antibodies for medical purposes, namely, for the treatment of cancer; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; pharmaceutical preparations for veterinary use, namely, veterinary pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, namely, for the prevention and treatment of cancer; antibody dr...
t2pd

General Information


Serial Number97144804
Word MarkT2PD
Filing DateSaturday, November 27, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements


Description of MarkThe mark consists of the letter "T", followed by a superscripted "2", followed by the letters "P" and "D".
Goods and Servicesbiopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; anti-cancer preparations; pharmaceutical compounds for treating cancer; drugs for medical purposes, namely, pharmaceutical drugs for the prevention and treatment of cancer; medicines for human purposes, namely, for the prevention and treatment of cancer; antibodies for medical purposes, namely, for the treatment of cancer; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; pharmaceutical preparations for veterinary use, namely, veterinary pharmaceutical preparations for the treatment of cancer; biological preparations for medical and veterinary purposes, namely, for the prevention and treatment of cancer; antibody drug conjugates for medical purposes, namely, for the prevention and treatment of cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOrum Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDaejeon 34050
KR

Party NameOrum Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDaejeon 34050
KR

Trademark Events


Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 16, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 3, 2022ASSIGNED TO EXAMINER
Wednesday, December 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 1, 2021NEW APPLICATION ENTERED